CT26 tumor-bearing BALB/c mice were treated intraperitoneally (i.p.)with 10 mg per kg anti-PD-L1 Abs, 2.5 mg per kg FimH, and a combination of anti-PD-L1 Abs and FimH every 5 days until 25 days after tumor injection. Here, CD274 is linked to neoplasm.